/RBSH
RBSH Stock - Rebus Holdings, Inc.
Healthcare|BiotechnologyOTC
$0.00+0.00%
+$0.00 (+0.00%) • Dec 19
47
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.50
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.0
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.00
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for RBSH
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.00 – $0.00
TARGET (TP)$0.00
STOP LOSS$0.00
RISK/REWARD1:-1.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta10.00
52W High$0.00
52W Low$0.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | $-35,000 | $-19,000 |
| Gross Margin | N/A | N/A | N/A | N/A | N/A |
| Operating Income | $-664,000 | $-1,022,000 | $-2,481,000 | $-609,000 | $-724,000 |
| Net Income | $-1,020,000 | $2.70M | $-6,295,000 | $-934,000 | $-12,000 |
| Net Margin | N/A | N/A | N/A | N/A | N/A |
| EPS | $-0.03 | $0.35 | $-10.93 | $-547.59 | $-7.98 |
Company Overview
Rebus Holdings, Inc. focuses on the research and development of precision therapeutics for the treatment of cancer. Its lead asset is RT-AR001, an adenosine receptor antagonist for tumor infiltration and enhanced outcomes when administered intra-tumorally. The company was founded in 2003 and is based in Westlake Village, California.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
RBSHBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$0.00
Q2 2023
EPS Surprise History
Q3 21
No data
Q4 21
No data
Q2 22
No data
Q3 22
No data
Q3 22
No data
Q4 22
No data
Q1 23
No data
Q2 23
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2023 | Jun 30, 2023 | — | $0.00 | — | — |
Q1 2023 | Mar 31, 2023 | — | $-0.02 | — | — |
Q4 2022 | Dec 31, 2022 | — | $0.05 | — | — |
Q3 2022 | Sep 30, 2022 | — | $0.00 | — | — |
Q3 2022 | Aug 11, 2022 | — | $-0.04 | — | — |
Q2 2022 | May 13, 2022 | — | $-0.02 | — | — |
Q4 2021 | Dec 31, 2021 | — | $0.00 | — | — |
Q3 2021 | Sep 30, 2021 | — | $0.16 | — | — |
Q2 2021 | Jun 30, 2021 | — | $0.45 | — | — |
Q1 2021 | Mar 31, 2021 | — | $-3.64 | — | — |
Q4 2020 | Dec 31, 2020 | — | $-1.15 | — | — |
Q3 2020 | Sep 30, 2020 | — | $0.29 | — | — |
Q2 2020 | Jun 30, 2020 | — | $-17.62 | — | — |
Q1 2020 | Mar 31, 2020 | — | $-26.74 | — | — |
Q4 2019 | Dec 31, 2019 | — | $-16.28 | — | — |
Q3 2019 | Sep 30, 2019 | — | $15.42 | — | — |
Q2 2019 | Jun 30, 2019 | — | $-311.52 | — | — |
Q1 2019 | Mar 31, 2019 | — | $-29.22 | — | — |
Q4 2018 | Dec 31, 2018 | — | $855.86 | — | — |
Q3 2018 | Sep 30, 2018 | — | $-7028.95 | — | — |
Latest News
Loading news...
Frequently Asked Questions about RBSH
What is RBSH's current stock price?
Rebus Holdings, Inc. (RBSH) is currently trading at $0.00 per share. The stock has moved +0.00% today.
What is the analyst price target for RBSH?
No analyst price targets are currently available for this stock.
What sector is Rebus Holdings, Inc. in?
Rebus Holdings, Inc. operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the OTC exchange.
What is RBSH's market cap?
Rebus Holdings, Inc. has a market capitalization of $0.00 billion, making it a small-cap company.
Does RBSH pay dividends?
No, Rebus Holdings, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorANTH
Anthera Pharmaceuticals, Inc.
$0.00
Mkt Cap: $0.0B
CMRA
Comera Life Sciences Holdings, Inc.
$0.00
Mkt Cap: $0.0B
FPMI
FluoroPharma Medical, Inc.
$0.00
Mkt Cap: $0.0B
GBIM
GlobeImmune, Inc.
$0.00
Mkt Cap: $0.0B
NLVVF
New Leaf Ventures Inc
$0.00
Mkt Cap: $0.0B
NTII
Neurobiological Technologies, Inc.
$0.00
Mkt Cap: $0.0B
PZRXQ
PhaseRx, Inc.
$0.00
Mkt Cap: $0.0B
SNNAQ
Sienna Biopharmaceuticals, Inc.
$0.00
Mkt Cap: $0.0B
SYVC
Synovics Pharmaceuticals, Inc.
$0.00
Mkt Cap: $0.0B
TNGNQ
Tengion, Inc.
$0.00
Mkt Cap: $0.0B
Explore stocks similar to RBSH for comparison